Approved for Heart failure with reduced ejection fraction. Combines neprilysin inhibition with ARB to reduce cardiac workload. Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels, openFDA FAERS, and CMS NADAC pricing.
Loading full data from Know Your Drugs Institute…